Interní Med. 2002; 4(9): 460-466

Ambulantní antikoagulační léčba kumariny

prof. MUDr. Jaroslav Malý CSc
I. interní klinika Fakultní nemocnice v Hradci Králové

Published: December 31, 2002  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Malý J. Ambulantní antikoagulační léčba kumariny. Interní Med. 2002;4(9):460-466.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. ACCP Consensus Committee on Pulmonary Embolism. Opinions regarding the diagnosis and management of venous thromboembolic disease. Chest 1998; 113: 499-504. Go to original source... Go to PubMed...
    2. Agnelli G, Sonaglia F. Prevention of venous thromboembolism. Thrombosis Res 2000; 97: V49-V62. Go to original source... Go to PubMed...
    3. American Thoracic Society - an offical statement. The Diagnostic Approach to Acute Venous Thromboembolism. Clinical Practice Guideline. Am J Respir Care Med 1999; 160: 1043-1066. Go to original source... Go to PubMed...
    4. Andrew M, Brooker LA, Ginsberg JS, Kelton JG. Clinical problems in anticoagulation therapy. Hematology, Education program. Am Soc Hematol 1997: 8-28.
    5. Ansell J., Hirsh J., Dalen J. et al. Managing oral anticoagulant therapy. Chest 2000; 119: 22S-38S. Go to original source... Go to PubMed...
    6. Bates SM, Hirsh J. Treatment of venous thromboembolism. Thromb. Haemostas 1999; 82: 870-877. Go to original source... Go to PubMed...
    7. Goldhaber SZ. Optimizing anticoagulant therapy in the management of pulmonary embolism. Sem Thromb Hemostas 1999; 25 (suppl. 3): 129-133. Go to original source...
    8. Hirsh J, Dalen JE, Andersson DR, et al. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 2000; 119: 8S-21S. Go to original source... Go to PubMed...
    9. Hyers TM, Agnelli G, Hull RD, et al. Antitrombotic therapy for venous thromboembolic disease. Chest 2001; 119: 176S-193S. Go to original source... Go to PubMed...
    10. Kearon C, Gent M, Hirsh J, et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med 1999; 340: 901-907. Go to original source... Go to PubMed...
    11. Matýšková M, Zavřelová J, Hrachovinová I. Hematologie, Krevní srážení IDVZ, Brno 1999: 204s.
    12. Research Committee of the British Thoracic Society. Optimal duration of anticoagulation for deep vein thrombosis and pulmonary embolism. Lancet 1992; 340: 873-876. Go to original source...
    13. Riedel M. Choroby plicního oběhu. Galén Praha 2000: 295s.
    14. Schulman S, Granqvist S, Holmstrom M. et al. The duration of anticoagulant therapy after a second episode of venous thromboembolism. N Engl J Med 1997; 336: 393-398. Go to original source... Go to PubMed...
    15. Task Force Report. Task Force on Pulmonary Embolism, European Society of Cardiology. Guidelines on diagnosis and management of acute pulmonary embolism. Eur Heart J 2000; 21: 1301-1336. Go to original source... Go to PubMed...
    16. Widimský J, Malý J. Doporučení diagnostiky a léčby plicní embolie. Cor Vasa 1998; 40: K 139-154.
    17. Widimský J, Malý J. Akutní plicní embolie a žilní trombóza, Nakl Triton 2002: 304s.

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.